Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
17.21
-0.09 (-0.52%)
At close: Jan 29, 2026
Extendicare Revenue
Extendicare had revenue of 383.45M CAD in the quarter ending June 30, 2025, with 10.03% growth. This brings the company's revenue in the last twelve months to 1.51B, up 8.68% year-over-year. In the year 2024, Extendicare had annual revenue of 1.47B with 12.36% growth.
Revenue (ttm)
1.51B CAD
Revenue Growth
+8.68%
P/S Ratio
1.41
Revenue / Employee
64.20K CAD
Employees
23,500
Market Cap
1.61B USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.47B | 161.25M | 12.36% |
| Dec 31, 2023 | 1.30B | 83.38M | 6.83% |
| Dec 31, 2022 | 1.22B | 54.59M | 4.68% |
| Dec 31, 2021 | 1.17B | 63.44M | 5.75% |
| Dec 31, 2020 | 1.10B | -28.41M | -2.51% |
| Dec 31, 2019 | 1.13B | 11.94M | 1.07% |
| Dec 31, 2018 | 1.12B | 22.68M | 2.07% |
| Dec 31, 2017 | 1.10B | 36.57M | 3.45% |
| Dec 31, 2016 | 1.06B | 117.48M | 12.45% |
| Dec 31, 2015 | 943.28M | 127.16M | 15.58% |
| Dec 31, 2014 | 816.12M | 32.31M | 4.12% |
| Dec 31, 2013 | 783.81M | -1.25B | -61.53% |
| Dec 31, 2012 | 2.04B | -56.67M | -2.71% |
| Dec 31, 2011 | 2.09B | 122.31M | 6.20% |
| Dec 31, 2005 | 1.97B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Selectis Health | 42.17M |
| Regional Health Properties | 37.30M |
| Mid-Atlantic Home Health Network | 27.00M |
| Stem Cell Authority | 3.33M |
| Xcelerate | 2.70M |
| HealthLynked | 2.37M |
| BioCorRx | 948.36K |
Extendicare News
- 15 days ago - Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call - GlobeNewsWire
- 16 days ago - Extendicare Announces January 2026 Dividend of C$0.042 per Share - GlobeNewsWire
- 6 weeks ago - SANDPIPER GROUP REDUCES ITS POSITION IN EXTENDICARE INC. - Benzinga
- 6 weeks ago - Extendicare (EXETF) Declares Consistent Monthly Dividend - GuruFocus
- 7 weeks ago - Extendicare Announces December 2025 Dividend of C$0.042 per Share - GlobeNewsWire
- 2 months ago - Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares - GlobeNewsWire
- 2 months ago - Extendicare Inc. (EXE:CA) Pre Recorded M&A Call Prepared Remarks Transcript - Seeking Alpha
- 2 months ago - Extendicare Inc. (EXE:CA) CBI Home Health, Paramed, Inc. - Pre Recorded M&A Call - Slideshow - Seeking Alpha